What question did this study set out to answer?

Identify factors associated with central nervous system relapse in pediatric B-cell acute lymphoblastic leukemia (B-ALL).

December 8, 2025BloodOpen Access

Factors associated with central nervous system relapse after b-acute lymphoblastic leukemia: A Children's oncology group report

View Full Paper

Ask AI

Bookmark

Authors

Analysis shows that immunotherapy poses unique risks for CNS relapse in pediatric B-ALL, suggesting tailored therapies may be needed.

Identify factors associated with central nervous system relapse in pediatric B-cell acute lymphoblastic leukemia (B-ALL).
Analyzed data from Children's Oncology Group trials for de novo B-ALL
Evaluated isolated CNS and BM relapse rates among patients
Used proportional cause-specific hazards models for association estimation
10.3% of patients relapsed, with 21.2% having isolated CNS relapses
Found that demographic factors and blast genetics impact CNS relapse risk
Identified immunotherapy's role in CNS relapse risk, indicating a need for adjusted treatment strategies

Devidas et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark